Dapagliflozin
NDC 70954-856, Dapagliflozin, tablet, film coated, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-856
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211156
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-856 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN5 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-856-10 | 70954085610 | 30 TABLET, FILM COATED in 1 BOTTLE (70954-856-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6425d240-5dd9-4a2c-9348-f8a859702850NADAC price for package 70954085610
GET /v1/drugs/nadac/70954085610
Use it
Look up 70954-856 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-856 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-856. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.